Aldesleukin Recruiting Phase 1 Trials for Advanced Ovarian Cancer / Melanoma, Malignant Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03158935The ACTIVATE (Adoptive Cell Therapy InVigorated to Augment Tumor Eradication) Trial